Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P26
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -26.90% |
| Q3 2025 | 11.73% |
| Q2 2025 | 3.57% |
| Q1 2025 | -105.33% |
| Q4 2024 | 35.68% |
| Q3 2024 | -2.69% |
| Q2 2024 | 20.76% |
| Q1 2024 | -72.37% |
| Q4 2023 | 23.14% |
| Q3 2023 | 21.30% |
| Q2 2023 | 0.14% |
| Q1 2023 | -21.00% |
| Q4 2022 | -15.27% |
| Q3 2022 | 3.69% |
| Q2 2022 | -229.09% |
| Q1 2022 | 55.59% |
| Q4 2021 | -14.73% |
| Q3 2021 | -42.26% |
| Q2 2021 | -5.93% |
| Q1 2021 | -179.27% |
| Q4 2020 | 287.22% |
| Q3 2020 | 141.60% |
| Q2 2020 | 9.22% |
| Q1 2020 | -53.12% |
| Q4 2019 | 4.29% |
| Q3 2019 | 13.96% |
| Q2 2019 | 8.97% |
| Q1 2019 | -116.67% |
| Q4 2018 | 61.53% |
| Q3 2018 | -21.14% |
| Q2 2018 | 10.52% |
| Q1 2018 | -20.99% |
| Q4 2017 | 4.18% |
| Q3 2017 | 17.72% |
| Q2 2017 | -41.14% |
| Q1 2017 | -129.01% |
| Q4 2016 | 719.37% |
| Q3 2016 | -10.63% |
| Q2 2016 | 37.33% |
| Q1 2016 | -76.69% |